Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine

Vaccine

Volumn 24, Issue 14, 2006, Pages 2544-2549

  Bashir, Haitham El ^a,d   Heath, Paul T ^b   Papa, Thomas ^c   Ruggeberg, Jens U ^b   Johnson, Nik ^b   Sinha, Ruchi ^b   Balfour, Gail ^b   Booy, Robert ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c SANOFI PASTEUR   (France)

^d ST ANN S HOSPITAL   (United Kingdom)

Author keywords

Conjugate vaccine; Meningococcal disease; Neisseria meningitidis; Serogroup C

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BEHAVIOR DISORDER; BLOOD ANALYSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEBRILE CONVULSION; FEMALE; HEMATOMA; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INJECTION SITE PAIN; INJECTION SITE REACTION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VACCINATION REACTION;

ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CHILD, PRESCHOOL; DIPHTHERIA TOXOID; DOUBLE-BLIND METHOD; HUMANS; IMMUNOLOGIC MEMORY; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE;

EID: 33344462488     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.018     Document Type: Article

References (29)

1. N.E. Rosenstein, B.A. Perkins, D.S. Stephens, T. Popovic, and J.M. Hughes Meningococcal disease N Engl J Med 344 2001 1378 1388
2. E.B. Kaczmarski Meningococcal disease in England and Wales: 1995 Commun Dis Rep CDR Rev 7 1998 R55 R59
3. J. Fogarty Trends in serogroup C meningococcal disease in the Republic of Ireland Eurosurveillance 2 1998 75 76
4. S. Mateo, R. Cano, and C. Garcia Changing epidemiology of meningococcal disease in Spain, 1989-1997 Eurosurveillance 2 1998 71 74
5. P. Krizova, J. Vlckova, and M. Bobak Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic Epidemiol Mikrobiol Imunol 44 1995 9 14
6. C.M. Whalen, J.C. Hockin, A. Ryan, and F. Ashton The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitides JAMA 273 1995 390 394
7. C.T. Sacchi, R.C. Zanella, D.A. Caugant, C.E. Frasch, N.T. Hidalgo, and L.G. Milagres Emergence of a new clone of serogroup C Neisseria meningitidis in Sao Paulo, Brazil J Clin Microbiol 30 1992 1282 1286
8. M. Ramsay, E. Kaczmarski, M. Rush, R. Mallard, P. Farrington, and J. White Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales Commun Dis Rep CDR Rev 7 1997 R49 R54
9. E. Miller, D. Salisbury, and M. Ramsey Planning, registration, and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story Vaccine 20 2002 S58 S67
10. C.L. Trotter, N.J. Andrews, E.B. Kaczmarski, E. Miller, and M.E. Ramsey Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction Lancet 364 2004 365 367
11. M.C. Maiden, J.M. Stuart UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination Lancet 359 2002 1829 1831
12. M.E. Ramsey, N.J. Andrews, C.L. Trotter, E.B. Kaczmarski, and E. Miller Herd Immunity from meningococcal serogroup C conjugate vaccination in England: database analysis BMJ 326 2003 365 366
13. A. Bose, P. Coen, J. Tully, R. Viner, and R. Booy Effectiveness of meningococcal C conjugate vaccine in teenagers in England Lancet 361 2003 675 676
14. S.J. Hahne, S.J. Gray, J-F. Aguilera, N.S. Crowcroft, T. Nichols, and E.B. Kaczmarski W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001 Lancet 359 2002 582 583
15. R. Klaber, R. Booy, H. El Bashir, A. Mifsud, and S. Taylor Sustained outbreak of W135 meningococcal disease in east London, UK Lancet 360 2002 644
16. J.A. Racoosin, C.G. Whitney, C.S. Conover, and P.S. Diaz Serogroup Y meningococcal disease in Chicago, 1991-1997 JAMA 280 1998 2094 2098
17. M. Pichichero, J. Casey, M. Blatter, E. Rothstein, R. Ryall, and M. Bybel Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children Pediatr Infect Dis J 24 2005 57 62
18. M. Rennels, J. King Jr., R. Ryall, T. Papa, and J. Froeschle Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants Pediatr Infect Dis J 23 2004 429 435
19. P.T. Heath, and M.E. Ramsay Haemophilus influenzae type b vaccine-booster campaign BMJ 326 2003 1158 1159
20. S.E. Maslanka, L.L. Gheesling, D.E. Libutti, K.B. Donaldson, H.S. Harakch, and J.K. Dykes Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays: the multilaboratory study group Clin Diagn Lab Immunol 4 1997 156 167
21. M.D. Snape, D.F. Kelly, B. Green, E.R. Moxon, R. Borrow, and A.J. Pollard Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine Pediatr Infect Dis J 24 2005 128 131
22. R. Borrow, N. Andrews, D. Goldblatt, and E. Miller Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun 69 2001 1568 1573
23. P. Balmer, and R. Borrow Serologic correlates of protection for evaluating the response to meningococcal vaccines. Exp Rev Vaccines 3 2004 77 87
24. Keyserling H, Papa T, Bybel M. Age-related immune response to meningococcal vaccines. In: 4th Pediatric Infectious Diseases Society Conference, 12-14 October 2003.
25. M.P. Glode, J.B. Robbins, T.Y. Liu, E.C. Gotschlich, I. Orskov, and F. Orskov Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and Escherichia coli K92 J Infect Dis 135 1977 94 104
26. J.M. Braun, J. Beuth, C.C. Blackwell, S. Giersen, P.G. Higgins, and G. Tzanakaki Neisseria meningitides Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens Vaccine 22 2004 898 908
27. H. El Bashir, R. Klaber, and R. Booy W135 meningococcal pericarditis: report of 2 cases and review of literature Pediatr Infect Dis J 23 2004 969 970
28. M. Rennels, J. King, R. Ryall, S. Manoff, T. Papa, and A. Weddle Dose escalation, safety and immunogenicity study of a tetravalent meningococcal polysaccharide diphtheria conjugate vaccine in toddlers Pediatr Infect Dis J 21 2002 978 979
29. G. Campagne, A. Garba, P. Fabre, A. Schuchat, R. Ryall, and D. Boulanger Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger Pediatr Infect Dis J 19 2000 144 150